CoChat

Knock-out and transgenic mouse models of tauopathies

Open access
Denk, Franziska, Wade-Martins, Richard · 2009 · Neurobiology of Aging
Cited by 120

The DOI matches its Crossref record; 32 of the 32 references it cites were found in a registry or an index.

Abstract

Tauopathies, characterized by the dysfunction and aggregation of the microtubule-associated protein tau (MAPT), represent some of the most devastating neurodegenerative disorders afflicting the elderly, including Alzheimer's disease and progressive supranuclear palsy. Here we review the range of Mapt knock-out and MAPT transgenic mouse models which have proven successful at providing insights into the molecular mechanisms of neurodegenerative disease. In this overview we highlight several themes, including the insights such models provide into the cellular and molecular mechanisms of tauopathy, the direct relationship between neuropathology and behaviour, and the use of mouse models to help provide a platform for testing novel therapies. Mouse models have helped clarify the relationship between pathological forms of tau, cell death, and the emergence of disease, as well as the interaction between tau and other disease-associated molecules, such as the Aβ peptide. Finally, we discuss potential future MAPT genomic DNA models to investigate the importance of alternative splicing of the MAPT locus and its role in sporadic tauopathies.

Overview

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1016/j.neurobiolaging.2007.05.010

Cites

32 of 32 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 32 references

Research works printed but not linked: 62

  1. Allen, 2002, Abundant tau filaments and nonapoptotic neurodegeneration in transgenic mice expressing human P301S tau protein, J. Neurosci., 22, 9340, 10.1523/JNEUROSCI.22-21-09340.2002 · DOI · Paper page
  2. Andreadis, 1992, Structure and novel exons of the human tau gene, Biochemistry, 31, 10626, 10.1021/bi00158a027 · DOI · Paper page
  3. Bellucci, 2004, Induction of inflammatory mediators and microglial activation in mice transgenic for mutant human P301S tau protein, Am. J. Pathol., 165, 1643, 10.1016/S0002-9440(10)63421-9 · DOI · Paper page
  4. Boekhoorn, 2006, Improved long-term potentiation and memory in young tau-P301L transgenic mice before onset of hyperphosphorylation and tauopathy, J. Neurosci., 26, 3514, 10.1523/JNEUROSCI.5425-05.2006 · DOI · Paper page
  5. Brandt, 2005, Tau alteration and neuronal degeneration in tauopathies: mechanisms and models, Biochim. Biophys. Acta, 1739, 331, 10.1016/j.bbadis.2004.06.018 · DOI · Paper page
  6. Brion, 1999, Transgenic expression of the shortest human tau affects its compartmentalization and its phosphorylation as in the pretangle stage of Alzheimer's disease, Am. J. Pathol., 154, 255, 10.1016/S0002-9440(10)65272-8 · DOI · Paper page
  7. Caffrey, 2006, Haplotype-specific expression of exon 10 at the human MAPT locus, Hum. Mol. Genet., 15, 3529, 10.1093/hmg/ddl429 · DOI · Paper page
  8. Chambers, 1999, Overexpression of four-repeat tau mRNA isoforms in progressive supranuclear palsy but not in Alzheimer's disease, Ann. Neurol., 46, 325, 10.1002/1531-8249(199909)46:3<325::AID-ANA8>3.0.CO;2-V · doi:10.1002/1531-8249(199909)46:3<325::aid-ana8>3.0.co;2-v
  9. Conrad, 1997, Genetic evidence for the involvement of tau in progressive supranuclear palsy, Ann. Neurol., 41, 277, 10.1002/ana.410410222 · DOI · Paper page
  10. Delacourte, 1998, Vulnerable neuronal subsets in Alzheimer's and Pick's disease are distinguished by their tau isoform distribution and phosphorylation, Ann. Neurol., 43, 193, 10.1002/ana.410430209 · DOI · Paper page
  11. Dickey, 2007, Brain CHIP: removing the culprits in neurodegenerative disease, Trends Mol. Med., 13, 32, 10.1016/j.molmed.2006.11.003 · DOI
  12. Di Maria, 2000, Corticobasal degeneration shares a common genetic background with progressive supranuclear palsy, Ann. Neurol., 47, 374, 10.1002/1531-8249(200003)47:3<374::AID-ANA15>3.0.CO;2-8 · doi:10.1002/1531-8249(200003)47:3<374::aid-ana15>3.0.co;2-8
  13. D'Souza, 2005, Regulation of tau isoform expression and dementia, Biochim. Biophys. Acta, 1739, 104, 10.1016/j.bbadis.2004.08.009 · DOI
  14. Duff, 2000, Characterization of pathology in transgenic mice over-expressing human genomic and cDNA tau transgenes, Neurobiol. Dis., 7, 87, 10.1006/nbdi.1999.0279 · DOI · Paper page
  15. Egashira, 2005, Altered depression-related behavior and neurochemical changes in serotonergic neurons in mutant R406W human tau transgenic mice, Brain Res., 1059, 7, 10.1016/j.brainres.2005.08.004 · DOI
  16. Fung, 2006, Association of tau haplotype-tagging polymorphisms with Parkinson's disease in diverse ethnic Parkinson's disease cohorts, Neurodegener. Dis., 3, 327, 10.1159/000097301 · DOI
  17. Geschwind, 2003, Tau phosphorylation, tangles, and neurodegeneration: the chicken or the egg?, Neuron, 40, 457, 10.1016/S0896-6273(03)00681-0 · DOI
  18. Gotz, 1995, Somatodendritic localization and hyperphosphorylation of tau protein in transgenic mice expressing the longest human brain tau isoform, EMBO J., 14, 1304, 10.1002/j.1460-2075.1995.tb07116.x · DOI · Paper page
  19. Gotz, 2001, Oligodendroglial tau filament formation in transgenic mice expressing G272V tau, Eur. J. Neurosci., 13, 2131, 10.1046/j.0953-816x.2001.01604.x · DOI · Paper page
  20. Harada, 1994, Altered microtubule organization in small-calibre axons of mice lacking tau protein, Nature, 369, 488, 10.1038/369488a0 · DOI · Paper page
  21. Healy, 2004, Tau gene and Parkinson's disease: a case-control study and meta-analysis, J. Neurol. Neurosurg. Psychiatry, 75, 962, 10.1136/jnnp.2003.026203 · DOI · Paper page
  22. Hernandez, 2004, Glycogen synthase kinase-3 plays a crucial role in tau exon 10 splicing and intranuclear distribution of SC35 Implications for Alzheimer's disease, J. Biol. Chem., 279, 3801, 10.1074/jbc.M311512200 · DOI · Paper page
  23. Higuchi, 2002, Transgenic mouse model of tauopathies with glial pathology and nervous system degeneration, Neuron, 35, 433, 10.1016/S0896-6273(02)00789-4 · DOI · Paper page
  24. Higuchi, 2005, Axonal degeneration induced by targeted expression of mutant human tau in oligodendrocytes of transgenic mice that model glial tauopathies, J. Neurosci., 25, 9434, 10.1523/JNEUROSCI.2691-05.2005 · DOI · Paper page
  25. Ikegami, 2000, Muscle weakness, hyperactivity, and impairment in fear conditioning in tau-deficient mice, Neurosci. Lett., 279, 129, 10.1016/S0304-3940(99)00964-7 · DOI · Paper page
  26. Ishihara, 2001, Age-dependent induction of congophilic neurofibrillary tau inclusions in tau transgenic mice, Am. J. Pathol., 158, 555, 10.1016/S0002-9440(10)63997-1 · DOI · Paper page
  27. Karnik, 2006, Non-fluent progressive aphasia, depression, and OCD in a woman with progressive supranuclear palsy: neuroanatomical and neuropathological correlations, Neurocase, 12, 332, 10.1080/13554790601125957 · DOI
  28. Katsuse, 2006, Neurofibrillary tangle-related synaptic alterations of spinal motor neurons of P301L tau transgenic mice, Neurosci. Lett., 409, 95, 10.1016/j.neulet.2006.09.021 · DOI
  29. Lambourne, 2005, Increased tau phosphorylation on mitogen-activated protein kinase consensus sites and cognitive decline in transgenic models for Alzheimer's disease and FTDP-17: evidence for distinct molecular processes underlying tau abnormalities, Mol. Cell. Biol., 25, 278, 10.1128/MCB.25.1.278-293.2005 · DOI · Paper page
  30. Laws, 2007, Fine mapping of the MAPT locus using quantitative trait analysis identifies possible causal variants in Alzheimer's disease, Mol. Psychiatry., 12, 510, 10.1038/sj.mp.4001935 · DOI
  31. Lim, 2001, FTDP-17 mutations in tau transgenic mice provoke lysosomal abnormalities and Tau filaments in forebrain, Mol. Cell. Neurosci., 18, 702, 10.1006/mcne.2001.1051 · DOI · Paper page
  32. Lin, 2003, Filamentous tau in oligodendrocytes and astrocytes of transgenic mice expressing the human tau isoform with the P301L mutation, Am. J. Pathol., 162, 213, 10.1016/S0002-9440(10)63812-6 · DOI
  33. Lin, 2003, Ultrastructural neuronal pathology in transgenic mice expressing mutant (P301L) human tau, J. Neurocytol., 32, 1091, 10.1023/B:NEUR.0000021904.61387.95 · DOI
  34. Lin, 2005, Progressive white matter pathology in the spinal cord of transgenic mice expressing mutant (P301L) human tau, J. Neurocytol., 34, 397, 10.1007/s11068-006-8726-0 · DOI
  35. Morozov, 2003, Using conditional mutagenesis to study the brain, Biol. Psychiatry, 54, 1125, 10.1016/S0006-3223(03)00467-0 · DOI
  36. Mukherjee, 2007, Haplotype-based association analysis of the MAPT locus in late onset Alzheimer's disease, BMC Genet., 8, 3, 10.1186/1471-2156-8-3 · DOI · Paper page
  37. Murakami, 2006, Cortical neuronal and glial pathology in TgTauP301L transgenic mice: neuronal degeneration, memory disturbance, and phenotypic variation, Am. J. Pathol., 169, 1365, 10.2353/ajpath.2006.051250 · DOI
  38. Myers, 2005, The H1c Haplotype at the MAPT locus is associated with Alzheimer's Disease, Hum. Mol. Genet., 14, 2399, 10.1093/hmg/ddi241 · DOI · Paper page
  39. Myers, 2007, The MAPT H1c risk haplotype is associated with increased expression of tau and especially of 4 repeat containing transcripts, Neurobiol. Dis., 25, 561, 10.1016/j.nbd.2006.10.018 · DOI · Paper page
  40. Nakashima, 2005, Chronic lithium treatment decreases tau lesions by promoting ubiquitination in a mouse model of tauopathies, Acta Neuropathol. (Berl.), 110, 547, 10.1007/s00401-005-1087-4 · DOI
  41. Pastor, 2004, Novel haplotypes in 17q21 are associated with progressive supranuclear palsy, Ann. Neurol., 56, 249, 10.1002/ana.20178 · DOI
  42. Pennanen, 2004, Accelerated extinction of conditioned taste aversion in P301L tau transgenic mice, Neurobiol. Dis., 15, 500, 10.1016/j.nbd.2003.11.020 · DOI · Paper page
  43. Pennanen, 2006, Impaired spatial reference memory and increased exploratory behavior in P301L tau transgenic mice, Genes Brain Behav., 5, 369, 10.1111/j.1601-183X.2005.00165.x · DOI · Paper page
  44. Perez, 2003, Chronic lithium treatment decreases mutant tau protein aggregation in a transgenic mouse model, J. Alzheimers Dis., 5, 301, 10.3233/JAD-2003-5405 · DOI · Paper page
  45. Pittman, 2005, Linkage disequilibrium fine-mapping and haplotype association analysis of the tau gene in progressive supranuclear palsy and corticobasal degeneration, J. Med. Genet., 42, 837, 10.1136/jmg.2005.031377 · DOI · Paper page
  46. Pittman, 2004, The structure of the tau haplotype in controls and in progressive supranuclear palsy, Hum. Mol. Genet., 13, 1267, 10.1093/hmg/ddh138 · DOI · Paper page
  47. Probst, 2000, Axonopathy and amyotrophy in mice transgenic for human four-repeat tau protein, Acta Neuropathol. (Berl.), 99, 469, 10.1007/s004010051148 · DOI · Paper page
  48. Santacruz, 2005, Tau suppression in a neurodegenerative mouse model improves memory function, Science, 309, 476, 10.1126/science.1113694 · DOI · Paper page
  49. Schindowski, 2006, Alzheimer's disease-like tau neuropathology leads to memory deficits and loss of functional synapses in a novel mutated tau transgenic mouse without any motor deficits, Am. J. Pathol., 169, 599, 10.2353/ajpath.2006.060002 · DOI · Paper page
  50. Shahani, 2002, Functions and malfunctions of the tau proteins, Cell. Mol. Life Sci., 59, 1668, 10.1007/PL00012495 · DOI · Paper page
  51. Skipper, 2004, Linkage disequilibrium and association of MAPT H1 in Parkinson disease, Am. J. Hum. Genet., 75, 669, 10.1086/424492 · DOI · Paper page
  52. Takanashi, 2002, Expression patterns of tau mRNA isoforms correlate with susceptible lesions in progressive supranuclear palsy and corticobasal degeneration, Brain Res. Mol. Brain Res., 104, 210, 10.1016/S0169-328X(02)00382-0 · DOI
  53. Takei, 2000, Defects in axonal elongation and neuronal migration in mice with disrupted tau and map1b genes, J. Cell Biol., 150, 989, 10.1083/jcb.150.5.989 · DOI · Paper page
  54. Tanemura, 2001, Formation of filamentous tau aggregations in transgenic mice expressing V337M human tau, Neurobiol Dis., 8, 1036, 10.1006/nbdi.2001.0439 · DOI · Paper page
  55. Tanemura, 2002, Neurodegeneration with tau accumulation in a transgenic mouse expressing V337M human tau, J. Neurosci., 22, 133, 10.1523/JNEUROSCI.22-01-00133.2002 · DOI · Paper page
  56. Taniguchi, 2005, Transgenic mice expressing mutant (N279K) human tau show mutation dependent cognitive deficits without neurofibrillary tangle formation, FEBS Lett., 579, 5704, 10.1016/j.febslet.2005.09.047 · DOI · Paper page
  57. Tatebayashi, 2002, Tau filament formation and associative memory deficit in aged mice expressing mutant (R406W) human tau, Proc. Natl. Acad. Sci. U.S.A., 99, 13896, 10.1073/pnas.202205599 · DOI · Paper page
  58. Terwel, 2005, Changed conformation of mutant Tau-P301L underlies the moribund tauopathy, absent in progressive, nonlethal axonopathy of Tau-4R/2N transgenic mice, J. Biol. Chem., 280, 3963, 10.1074/jbc.M409876200 · DOI · Paper page
  59. Yao, 2005, Preserved synaptic vesicle recycling in hippocampal neurons in a mouse Alzheimer's disease model, Biochem. Biophys. Res. Commun., 330, 34, 10.1016/j.bbrc.2005.02.121 · DOI
  60. Zehr, 2004, Apoptosis in oligodendrocytes is associated with axonal degeneration in P301L tau mice, Neurobiol. Dis., 15, 553, 10.1016/j.nbd.2003.12.011 · DOI · Paper page
  61. Zhang, 2004, Retarded axonal transport of R406W mutant tau in transgenic mice with a neurodegenerative tauopathy, J. Neurosci., 24, 4657, 10.1523/JNEUROSCI.0797-04.2004 · DOI · Paper page
  62. Zhang, 2005, The tau gene haplotype h1 confers a susceptibility to Parkinson's disease, Eur. Neurol., 53, 15, 10.1159/000082956 · DOI

Cited by

See all 120

Metadata

Authors
Denk, F., & Wade-Martins, R.
Venue
Neurobiology of Aging
Publisher
Elsevier BV
Published
2009-01
Volume
30
Issue
1
Pages
1-13
ISSN
0197-4580 (ISSN-L)
OpenAlex
W2053330721
Cited by
120
References
32
FWCI
3.16
Type
journal article
Language
en
Open access
green
Licence
www.elsevier.com/tdm/userlicense/1.0/ (tdm)

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Knock-out and transgenic mouse models of tauopathies. https://app.cochat.ai/papers/10.1016/j.neurobiolaging.2007.05.010
The paper
Denk, F., & Wade-Martins, R. (2009). Knock-out and transgenic mouse models of tauopathies. Neurobiology of Aging. https://doi.org/10.1016/j.neurobiolaging.2007.05.010

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.